Last reviewed · How we verify

NCT05384457

High Intensity Training to Improve Diaphragm Functioning in Persons With Chronic Nonspecific Low Back Pain

Status unknown NA Last updated 6 October 2022
What this trial tests

NA trial testing High intensity training in Low Back Pain in 64 participants. Status unknown.

Timeline
22 August 2022
Primary endpoint
1 June 2025
1 November 2025

Quick facts

Lead sponsorHasselt University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment64
Start date22 August 2022
Primary completion1 June 2025
Estimated completion1 November 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Hasselt University

Who can join

Adults 18 to 65, any sex, with Low Back Pain or Chronic Low-back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to investigate 1) the effects of high intensity training (HIT) compared to moderate intensity training (MIT) on diaphragm muscle strength, -endurance, -fatigue and -activation, 2) to which extent these changes in diaphragm functioning are related to changes in cardiorespiratory fitness, postural control, pain and disability after HIT versus MIT, 3) to which extent depressive mood and anxiety moderate the effects of HIT on diaphragm functioning in persons with chronic nonspecific low back pain (CNSLBP). The investigators hypothize that HIT improves diaphragm functioning more compared to MIT in persons with CNSLBP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05384457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing